Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Pathways involved in the osmotic shock response in yeast cells. A comprehensive model of this process that incorporates molecular and biophysical components is reported by Klipp et al.(p. 975). Photo by SciMAT/Photo Researchers, Inc.
Biotech industry may not be well represented on the new National Science Advisory Board for Biosecurity, but they will be watching closely from the sidelines.
Malaysia is embarking on an ambitious 15-year plan to foster a local biotech industry, but can it compete with countries like India and China, already engaged in the industry?
Can developing countries benefit from the drugs that are tested in their territory by virtual company outsourcing every step of the making of medicine there? Haseltine's recent experiences in India made him believe it is possible.
A decade of sound science and aggressive deal making has given Sangamo Biosciences a stranglehold on zinc finger technologies. Now, academic labs that helped build Sangamo's empire want in on the action. Are the ingredients ripe for a revolt that could break the company's monopoly? Christopher Thomas Scott investigates.
The current legal system fails to provide an equitable balance between the rights of researchers and the rights of donors of biological materials. Could the tax system provide a solution?
